PCN107 FIRST-LINE TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) WITH BEVACIZUMAB AND SOCIETAL COST SAVINGS IN SPAIN
Abstract
Authors
S Stanisic Carpeo JD Castro S Walzer
S Stanisic Carpeo JD Castro S Walzer
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now